Using agronomic measures to remediate heavy metals on farmland is the main measure to achieve the safe utilization of crops. Investigating the effects of applying different fertilizers on the uptake, and translocation of Chromium (Cr) in maize and on the effectiveness of Cr in soil under Cr contamination of farmland is of great theoretical and practical significance to achieve the safe utilization of arable land and safe production of agricultural products. Under field trial conditions, different fertilizer types were set up, including ammonium sulfite, calcium-magnesium phosphate, and diammonium phosphate. locally formulated fertilizers (urea-ammonium phosphate-potassium chloride) serving as the control, with Biochar and conditioner PX5B were chosen to compare the impacts of each. To study the effects of different fertilizer types on maize yield, Cr content in the plant, bioconcentration factor, translocation factor and available content of Cr in the soil. The results showed that Compared with the formulated fertilizer, all treatments could improve pH, soil organic matter (SOM） and reduce the effective state of Cr content in the soil by 15.05% to 42.66%. While the Cr content of maize grains treated with biochar and conditioner PX5B was 0.80 mg·kg-1 and 0.88 mg·kg-1 with reduction rates of 39.95% and 33.83%, respectively. The Cr content of maize grains treated with various fertilizer treatments ranged from 0.82 to 1.32 mg·kg-1 with reduction rates of 0.75% to 38.19%. The Cr content of maize grains could be brought down to below the national food safety standards of China(1.0 mg·kg-1) using urea – calcium magnesium phosphate - potassium chloride, urea - diammonium phosphate - potassium chloride, ammonium sulfite – calcium magnesium phosphate - potassium chloride and ammonium sulfite, urea – calcium magnesium phosphate - potassium chloride and the two conditioner treatments. Among the different fertilizer treatments, the best fertilizer treatment for reducing the effective state Cr content of soil and the Cr content of maize grains was ammonium sulfite-calcium-magnesium-phosphate fertilizer-potassium chloride, which could achieve similar reductions as the two conditioners, while it also had a certain reduction effect on the Cr content in maize roots and straws and on the aboveground bioconcentration factor（BCF） and the root-to-straw translocation factor（PTF） of maize for Cr. Therefore, the combination of ammonium sulfite and calcium magnesium phosphate is the best fertilizer combination to block the absorption of Cr by maize and has some implications for the fertilization of farmland under acidic soil conditions of Cr contamination.

Objective: To investigate the efficacy of a magnetic resonance imaging (MRI) radiomics model in predicting colorectal cancer liver metastasis (CRLM). Methods: A total of 120 patients who underwent baseline MRI examination at the Affiliated Hospital of North Sichuan Medical College from June 2016 to August 2022 and were pathologically confirmed to have colorectal cancer (CRC) were randomly divided into a training group and a validation group. The clinical risk factors and MRI data of all patients were collected. Univariate and multivariate analysis were used to screen the clinically independent risk factors for CRLM. The radiomic features of each sequence were extracted from oblique axial or axial fat-free T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) sequences. Least absolute shrinkage and selection operator (LASSO) regression was used to screen the optimal radiomic features of each sequence. Logistic regression was used to establish a prediction model of each sequence (T2WI and DWI models), a combined radiomics model (M) integrating the features of T2WI and DWI sequences, and a combined imaging-clinical model (U) combining the radiomic features of each sequence with clinically independent risk factors. The area under the receiver operating characteristic curve (AUC) was calculated to evaluate the predictive performance of each model. Results: Among the 120 CRC patients enrolled, 57 had liver metastasis, and 63 did not. The tumor markers carcinoembryonic antigen and carbohydrate antigen 19-9 were clinically independent risk factors for CRLM. Three optimal radiomic features were screened from T2WI and DWI sequences through LASSO regression analysis, respectively. The AUC values of the T2WI, DWI, M, and U models were 0.811, 0.803, 0.824, and 0.899 in the training group and 0.795, 0.798, 0.813, and 0.889 in the validation group, respectively. The predictive performance of the combined models was better than that of the single-sequence models. The U model performed best at predicting CRLM. Conclusion: An MRI radiomics model based on CRC primary lesions can predict CRLM well. Our combined model integrating the radiomic features of each sequence and clinically independent risk factors had the best predictive performance.

Simple summary: The noninvasive differentiation of hepatocellular carcinoma (HCC) from intrahepatic cholangiocarcinoma (ICC) remains challenging. In recent years, the number of studies on the application of radiomics in liver cancer has grown dramatically. However, there have been very few studies on the differentiation of HCC from ICC based on multisequence magnetic resonance imaging (MRI) radiomics. This study aimed to investigate the efficacy of a radiomic model based on preoperative fat suppression T2-weighted imaging (FS-T2WI) and dynamic contrast-enhanced MRI features in the arterial phase (A) and portal venous phase (P) for the differentiation of HCC from ICC. Abstract: The purpose of this study was to investigate the efficacy of magnetic resonance imaging (MRI) radiomics in differentiating hepatocellular carcinoma (HCC) from intrahepatic cholangiocarcinoma (ICC). The clinical and MRI data of 129 pathologically confirmed HCC cases and 48 ICC cases from April 2016 to December 2021 at the Affiliated Hospital of North Sichuan Medical College were retrospectively analyzed. Included cases were randomly divided at a ratio of 7:3 into a training group of 124 cases (90 HCC cases and 34 ICC cases) and a validation group of 53 cases (39 HCC cases and 14 ICC cases). Radiomic features were extracted from axial fat-suppression T2-weighted imaging (FS-T2WI) and axial arterial-phase (A) and portal-venous-phase (P) dynamic contrast-enhanced MRI sequences, and the corresponding datasets were generated. The least absolute shrinkage and selection operator (LASSO) method was used to select the best radiomic features. Logistic regression was used to establish a radiomic model for each sequence (FS-T2WI, A, and P models) and a joint model (M model) integrating the radiomic features of all the sequences. The performance of each model was evaluated using the area under the receiver operating characteristic curve (AUC). The AUC of the FS-T2WI, A, P, and M models for distinguishing HCC from ICC was 0.693, 0.863, 0.818, and 0.914 in the training group and 0.690, 0.784, 0.727, and 0.802 in the validation group, respectively. The results of this study suggest that MRI-based radiomics may help noninvasively differentiate HCC from ICC. The model integrating the radiomic features of multiple sequences showed further improvement in performance.